Key facts
- This page summarizes John Peter Mclaughlin's Form 4 filing for ROCKWELL MEDICAL, INC. (RMTI).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 22 Jun 2021, 17:25.
John Peter Mclaughlin - 17 Jun 2021 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)
- Reporting relationship
- Director
- Issuer ticker
- RMTI
- Reported as of
- 17 Jun 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 22 Jun 2021, 17:25:14 UTC
- Prior SEC filing
- 20 May 2021
- Next SEC filing
- 27 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael G. Costello, Attorney-in-Fact for John P. McLaughlin
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John Peter Mclaughlin filed Form 4 for ROCKWELL MEDICAL, INC. (RMTI) on 22 Jun 2021.
Change
- Previous filing in this sequence was filed on 20 May 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
RMTI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +50,000
- Change %
- +57%
- Price
- $0.000000
- Shares after
- 136,974
- Date
- 17 Jun 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RMTI
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +72,857
- Change %
- Price
- $0.000000
- Shares after
- 72,857
- Date
- 17 Jun 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 72,857
- Exercise price
- $0.9000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units vest on June 17, 2022, subject to the Reporting Person's continued service to the Issuer.
Footnote F2
Stock options shall vest in accordance with the following vesting schedule: (1) one-half (fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2023; and (2) the final one-half (remaining fifty percent) of the shares of Common Stock subject to this Option shall vest on June 17, 2025, subject to the Reporting Person's continued service to the Issuer.